{ "schemaVersion": 1, "organisationId": "O-dbb8e74daf854150bf3e16971be097d7", "slug": "davita-inc", "name": "DAVITA INC.", "updatedAt": "2026-10-02T13:01:26.938094Z", "sections": [ { "type": "OVERVIEW", "text": "DaVita Inc. is a healthcare company focused on kidney care, with dialysis and related laboratory services as its principal business. Its services span kidney-disease management through transplant support and are delivered in settings including patients’ homes, dialysis centers, hospitals and skilled nursing facilities. The company also provides integrated kidney care and operates internationally. [P146041793][P116748828][P109676028]\n\nDaVita’s stated mission is “to be the provider, partner and employer of choice.” [P116748828] For the year ended 2025, it reported revenue of approximately $13.6 billion. [T736829] The company reported more than 78,000 employees worldwide and care across more than 3,000 dialysis centers globally; as of September 30, 2025, it operated 3,247 outpatient dialysis centers, including 585 in 14 countries outside the United States. [https://investors.davita.com/wp-content/uploads/sites/3/2026/05/investors-annual-report-2025.pdf][https://newsroom.davita.com/2025-12-11-DaVita-Names-New-Leaders-to-Accelerate-Care-Transformation/]\n[P146041793][P116748828][P109676028][T736829][https://investors.davita.com/wp-content/uploads/sites/3/2026/05/investors-annual-report-2025.pdf][https://newsroom.davita.com/2025-12-11-DaVita-Names-New-Leaders-to-Accelerate-Care-Transformation/]", "updatedAt": "2026-10-02T13:01:26.938094Z" }, { "type": "PRODUCTS", "text": "DaVita’s core services include hemodialysis and related laboratory services. Hemodialysis uses a machine and dialyzer to filter blood across a semipermeable membrane, removing toxins, salt and excess fluid. It is provided in outpatient centers and other settings, including hospitals and patients’ homes. Home hemodialysis uses a smaller, portable machine, with DaVita providing training and ongoing support; treatment schedules can vary and are often more frequent than center-based schedules. [P109121214][P118397679][P113205035]\n\nDaVita also provides peritoneal dialysis, generally performed at home: continuous ambulatory peritoneal dialysis (CAPD) uses manual exchanges, while continuous cycling peritoneal dialysis (CCPD) uses a mechanical cycler, often during sleep or rest. [P69441111][P82070748][P99670744] Its integrated-care services include monitoring, clinical coordination, disease-management interventions, analytics and IT support for people with chronic or end-stage kidney disease; payment arrangements include contract fees, shared savings, pay-for-performance and capitation. [P109676028][P146041860]\n\nFor the six months ended June 30, 2026, U.S. dialysis accounted for approximately 85% of consolidated revenue and other ancillary services approximately 15%, based on reported segment revenue. [T16714970]\n[P109121214][P118397679][P113205035][P69441111][P82070748][P99670744][P109676028][P146041860][T16714970][T16714970][T16714970][T16714970][T16714970][T16714970]", "updatedAt": "2026-10-02T13:01:26.938094Z" }, { "type": "GEOGRAPHY", "text": "DaVita’s operations are concentrated in the United States. At year-end 2025, it operated 2,657 outpatient dialysis centers across 46 states and the District of Columbia, and provided inpatient dialysis services under contracts with approximately 740 U.S. hospitals. It also reported 585 outpatient centers in 14 countries outside the United States. [2025 annual report] [P47840387] [P50986494]\n[P47840387][P50986494][https://investors.davita.com/wp-content/uploads/sites/3/2026/05/investors-annual-report-2025.pdf]", "updatedAt": "2026-10-02T13:01:26.938094Z" }, { "type": "SEGMENTS", "text": "DaVita reports two reportable segments: **U.S. dialysis** and **Other—Ancillary services**. U.S. dialysis consists primarily of outpatient dialysis and related laboratory services; the company’s majority service is outpatient hemodialysis. “Other—Ancillary services” combines its remaining operating segments, including integrated kidney care (IKC), other U.S. ancillary services, and operations in foreign jurisdictions. IKC provides care management for people with chronic or end-stage kidney disease, including monitoring, care coordination, interventions, and analytics for health plans and government programs. [T16714986][T4489425][P24635761][P59101143]\n\nBy external revenue, U.S. dialysis contributed approximately **86%** of 2025 consolidated revenue ($11.732 billion), while Other—Ancillary services contributed approximately **14%** ($1.911 billion). Within ancillary revenue, the 2025 business-line and geographic breakdown was approximately **70% International** ($1.346 billion), **28% U.S. IKC** ($542 million), and **2% other U.S. ancillary services** ($34 million); these are revenue categories within the ancillary business, not additional reportable segments. [T16714986][T4489425][P109676028][P70314762]\n\nFor the six months ended June 30, 2026, U.S. dialysis represented approximately **85%** of consolidated external revenue ($5.922 billion), and Other—Ancillary services approximately **15%** ($1.048 billion). These percentages use external revenue, excluding intersegment sales, as a share of consolidated revenue. [T16714986][P81097221]\n[T16714986][T4489425][P24635761][P59101143][P109676028][P70314762][P81097221]", "updatedAt": "2026-10-02T13:01:26.938094Z" }, { "type": "HISTORY", "text": "DaVita’s corporate lineage began in 1994, when the company was incorporated as Medical Ambulatory Care Delaware, Inc. It was renamed Total Renal Care, Inc. later that year, then Total Renal Care Holdings, Inc. [https://www.davita.com/wp-content/uploads/sites/2/2025/04/davita-inc-restated-charter-signed-662023.pdf] In 1998, Total Renal Care acquired Renal Treatment Centers. [https://investors.davita.com/1999-4-1-Total-Renal-Care-Holdings-Inc-Announces-Filing-of-Form-10-K/] Kent J. Thiry became chairman and CEO in 1999; the company adopted the DaVita name in 2000. [https://investors.davita.com/1999-10-18-Kent-J-Thiry-Named-Chairman-and-Chief-Executive-Officer-of-Total-Renal-Care-Inc/][https://investors.davita.com/2000-10-04-Total-Renal-Care-Holdings-Inc-Announces-Legal-Name-Change-to-DaVita-Inc/]\n\nIn 2005, DaVita completed its acquisition of Gambro Healthcare’s U.S. operations, a major expansion of its dialysis business. [https://investors.davita.com/2005-10-05-DaVita-Closes-Gambro-Healthcare-Acquisition/] The company began expanding internationally in 2011 and, in 2012, merged with HealthCare Partners, broadening its activities into physician-led care; it later changed its name from DaVita HealthCare Partners Inc. back to DaVita Inc. in 2016. [https://www.davita.com/about/history-and-culture/][https://investors.davita.com/2012-11-1-DaVita-and-HealthCare-Partners-Finalize-Merger/][https://www.davita.com/wp-content/uploads/sites/2/2025/04/davita-inc-restated-charter-signed-662023.pdf] Javier J. Rodriguez succeeded Thiry as CEO in 2019, and that year Optum completed its acquisition of DaVita Medical Group. [https://investors.davita.com/2019-04-29-DaVita-Announces-CEO-Succession/][https://investors.davita.com/2019-06-19-Optum-completes-acquisition-of-DaVita-Medical-Group-from-DaVita/]", "updatedAt": "2026-10-02T13:01:26.938094Z" } ], "sources": [ { "id": "P146041793", "href": "https://app.finbar.com/go?id=P146041793", "label": "DAVITA INC. — Full financial report (2026 Q 2)", "documentId": "D-c5ed62d20ed043aab2ec5b712034a267" }, { "id": "P116748828", "href": "https://app.finbar.com/go?id=P116748828", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P109676028", "href": "https://app.finbar.com/go?id=P109676028", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "T736829", "href": "https://app.finbar.com/go?id=T736829", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "https://investors.davita.com/wp-content/uploads/sites/3/2026/05/investors-annual-report-2025.pdf", "href": "https://investors.davita.com/wp-content/uploads/sites/3/2026/05/investors-annual-report-2025.pdf", "label": "investors.davita.com" }, { "id": "https://newsroom.davita.com/2025-12-11-DaVita-Names-New-Leaders-to-Accelerate-Care-Transformation/", "href": "https://newsroom.davita.com/2025-12-11-DaVita-Names-New-Leaders-to-Accelerate-Care-Transformation/", "label": "newsroom.davita.com" }, { "id": "P109121214", "href": "https://app.finbar.com/go?id=P109121214", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P118397679", "href": "https://app.finbar.com/go?id=P118397679", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P113205035", "href": "https://app.finbar.com/go?id=P113205035", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P69441111", "href": "https://app.finbar.com/go?id=P69441111", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P82070748", "href": "https://app.finbar.com/go?id=P82070748", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P99670744", "href": "https://app.finbar.com/go?id=P99670744", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P146041860", "href": "https://app.finbar.com/go?id=P146041860", "label": "DAVITA INC. — Full financial report (2026 Q 2)", "documentId": "D-c5ed62d20ed043aab2ec5b712034a267" }, { "id": "T16714970", "href": "https://app.finbar.com/go?id=T16714970", "label": "DAVITA INC. — Full financial report (2026 Q 2)", "documentId": "D-c5ed62d20ed043aab2ec5b712034a267" }, { "id": "P47840387", "href": "https://app.finbar.com/go?id=P47840387", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P50986494", "href": "https://app.finbar.com/go?id=P50986494", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "T16714986", "href": "https://app.finbar.com/go?id=T16714986", "label": "DAVITA INC. — Full financial report (2026 Q 2)", "documentId": "D-c5ed62d20ed043aab2ec5b712034a267" }, { "id": "T4489425", "href": "https://app.finbar.com/go?id=T4489425", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P24635761", "href": "https://app.finbar.com/go?id=P24635761", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P59101143", "href": "https://app.finbar.com/go?id=P59101143", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P70314762", "href": "https://app.finbar.com/go?id=P70314762", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "P81097221", "href": "https://app.finbar.com/go?id=P81097221", "label": "DAVITA INC. — Full financial report (2025 Y)", "documentId": "D-2d607001a38c4db9b43edba692859ecf" }, { "id": "https://www.davita.com/wp-content/uploads/sites/2/2025/04/davita-inc-restated-charter-signed-662023.pdf", "href": "https://www.davita.com/wp-content/uploads/sites/2/2025/04/davita-inc-restated-charter-signed-662023.pdf", "label": "www.davita.com" }, { "id": "https://investors.davita.com/1999-4-1-Total-Renal-Care-Holdings-Inc-Announces-Filing-of-Form-10-K/", "href": "https://investors.davita.com/1999-4-1-Total-Renal-Care-Holdings-Inc-Announces-Filing-of-Form-10-K/", "label": "investors.davita.com" }, { "id": "https://investors.davita.com/1999-10-18-Kent-J-Thiry-Named-Chairman-and-Chief-Executive-Officer-of-Total-Renal-Care-Inc/", "href": "https://investors.davita.com/1999-10-18-Kent-J-Thiry-Named-Chairman-and-Chief-Executive-Officer-of-Total-Renal-Care-Inc/", "label": "investors.davita.com" }, { "id": "https://investors.davita.com/2000-10-04-Total-Renal-Care-Holdings-Inc-Announces-Legal-Name-Change-to-DaVita-Inc/", "href": "https://investors.davita.com/2000-10-04-Total-Renal-Care-Holdings-Inc-Announces-Legal-Name-Change-to-DaVita-Inc/", "label": "investors.davita.com" }, { "id": "https://investors.davita.com/2005-10-05-DaVita-Closes-Gambro-Healthcare-Acquisition/", "href": "https://investors.davita.com/2005-10-05-DaVita-Closes-Gambro-Healthcare-Acquisition/", "label": "investors.davita.com" }, { "id": "https://www.davita.com/about/history-and-culture/", "href": "https://www.davita.com/about/history-and-culture/", "label": "www.davita.com" }, { "id": "https://investors.davita.com/2012-11-1-DaVita-and-HealthCare-Partners-Finalize-Merger/", "href": "https://investors.davita.com/2012-11-1-DaVita-and-HealthCare-Partners-Finalize-Merger/", "label": "investors.davita.com" }, { "id": "https://investors.davita.com/2019-04-29-DaVita-Announces-CEO-Succession/", "href": "https://investors.davita.com/2019-04-29-DaVita-Announces-CEO-Succession/", "label": "investors.davita.com" }, { "id": "https://investors.davita.com/2019-06-19-Optum-completes-acquisition-of-DaVita-Medical-Group-from-DaVita/", "href": "https://investors.davita.com/2019-06-19-Optum-completes-acquisition-of-DaVita-Medical-Group-from-DaVita/", "label": "investors.davita.com" } ] }